Log in to save to my catalogue

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_289669043ba44633ae136b408c2f398a

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia

About this item

Full title

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia

Publisher

Switzerland: MDPI AG

Journal title

Biomedicines, 2022-03, Vol.10 (4), p.771

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Familial hypercholesterolemia (FH) is an autosomal dominant trait characterized by elevated LDL-C concentrations and is associated with an increased risk of premature atherosclerosis. Progranulin (PGRN) is a multifunctional protein that is known to have various anti-atherogenic effects. To date, the use of serum PGRN in patients with FH...

Alternative Titles

Full title

Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_289669043ba44633ae136b408c2f398a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_289669043ba44633ae136b408c2f398a

Other Identifiers

ISSN

2227-9059

E-ISSN

2227-9059

DOI

10.3390/biomedicines10040771

How to access this item